National and Kapodistrian University of Athens
Επιπρόσθετη διαγνωστική και προγνωστική αξία της κοπεπτίνης πλάσματος στους διαγνωστικούς αλγορίθμους υψηλής ευαισθησίας τροπονίνης της μιας και δυο ωρών σε ασθενείς με θωρακικό άλγος
Abstract
dc:descriptionBackground: Copeptin, a biomarker of endogenous stress, has been used for the early detection of patients with Acute Myocardial Infraction presenting to the Emergency Department (ED) with chest pain in combination with cardiac troponin, a marker of myocardial injury. Although its importance in conjunction with conventional troponin is well established, evidence regarding its additive value with high-sensitive troponin is contradictory. Combination of rule-out biomarker strategies and clinical risk scores may optimize prompt identification and management of low-risk patients. Aim: To evaluate the supplemental diagnostic value of copeptin in combination with high sensitive troponin T (hs-cTnT) upon presentation to the ED (dual marker strategy, DMS) and the additional benefit of the Heart Score (HS) for Major Cardiac Events in combination with copeptin. We sought to compare these strategies to the recommended by the European Society of Cardiology (ESC) algorithms 0h/1h and 0h/2h for ruling-out Non-ST elevation Myocardial Infraction (NSTEMI). Moreover, our aim was to assess safety of a DMS and prognostic utility of copeptin upon patient presentation. Methods: In a prospective diagnostic accuracy study (ΤΕΠ, ΕΒΔ 347/02/07/2021), from September 2021 to October 2023, we enrolled 102 patients presenting to the ED complaining of chest pain <6 hours; we excluded patients with STEMI. In the total population (N=102) we measured copeptin and hs-cTnT levels upon patient presentation (time 0h, cop_0h and hs-cTnT_0h, respectively) and we calculated HS. Hs-cTnT measurement was repeated either 1 hour (N=51) or 2 hours (N=51) after first measurement. Statistical analysis was performed so as to compare the diagnostic accuracy of the DMS, (cut-off copeptin<10ppmol/L, hs-cTnT<14ng/L) and the combination of copeptin plus a low modified HS in respect to the ESC algorithms 0/1h and 0/2h for ruling-out NSTEMI, according to ESC guidelines. Results: 59.8% of the population were men, with a mean age of 76±18 years. 8.8% of patients were diagnosed with NSTEMI. The dual marker strategy (cop_0h and hs-cTnT_0h) upon patient presentation demonstrated sensitivity of 88.9% (95% CI: 51.7–99.7) and negative predictive value (NPV) of 98.5% (95% CI: 90.9–99.8). Addition of the HS (0-3) improved diagnostic performance as sensitivity and NPV increased [100% (95%CI: 66.4-100) and 100% (95%CI: 91.6-100)], respectively. On the other hand, the 0h/1h algorithm showed a sensitivity of 60% (95% CI: 14.7–94.7) and NPV of 95.6% (95% CI: 88.1–98.4) and the 0h/2h algorithm had sensitivity of 75% (95% CI: 19.4–99.4) and NPV of 95.8% (95% CI: 85.2–98.9). The DMS effectively ruled-out 62.7% of patients upon presentation (64/102), (1 false negative subject). Addition of low HS to copeptin increased safety, as it ruled-out 41.2% of patients (42/102) with no false negative subjects. Copeptin could predict admission to hospital with an AUC of 0.742 (95% CI: 0.615-0.869).Conclusion: The dual marker strategy has a comparable diagnostic accuracy to the ESC algorithms 0h/1h and 0h/2h for the early rule-out of NSTEMI patients. Clinical and biomarker-guided diagnostic algorithms may enhance the diagnostic accuracy and safety of the early rule-out of patients suspected for NSTEMI just upon patient presentation. Multimodal strategies may aid in alleviating overcrowding in the ED.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bezati, Sofia
- Μπεζάτη, Σοφία
Subjects
dc:subject × 20- Κοπεπτίνη
- Θωρακικό άλγος
- Καρδιακή τροπονίνη
- Αλγόριθμος
- Τμήμα επειγόντων περιστατικών
- Αποκλεισμός
- Οξύ έμφραγμα μυοκαρδίου
- Copeptin
- Chest pain
- Cardiac troponin T
- Algorithm
- Emergency department
- Rule-out
- Acute myocardial infarction
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Επείγουσα ιατρική
- Clinical Medicine
- Medical and Health Sciences
- Emergency Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/62486